Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-028902
Filing Date
2025-06-02
Accepted
2025-06-02 19:31:04
Documents
3
Period of Report
2025-05-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1748907056.html 4  
1 FORM 4 wk-form4_1748907056.xml 4 6433
2 EX-24 sigal-form144andsection1.htm EX-24 3071
3 sigal-form144andsection1001.jpg GRAPHIC 190419
  Complete submission text file 0001628280-25-028902.txt   273313
Mailing Address 32 BREARLY ROAD PRINCETON NJ 08540
Business Address
Sigal Charles Elliott (Reporting) CIK: 0001661908 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39083 | Film No.: 251016796

Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Issuer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)